Trevi Therapeutics Inc (TRVI)
$13.56 -1.81% Close Oct 30, 2026 Live
Trevi Therapeutics stock today
Trevi Therapeutics closed at $13.56 on October 30, 2026, down 1.81% on the day. Over the past year it returned +21.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.93 billion.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | TRVI | S&P 500 (SPY) |
|---|---|---|
| 1 month | -5.3% | -0.9% |
| 3 months | -26.3% | +2.1% |
| Year to date | +8.3% | +11.7% |
| 1 year | +21.4% | +12.4% |
| 3 years | +641.0% | +88.5% |
| 5 years | +1,054% | +76.0% |
Key statistics
- Market value
- $1.93B
- 52-week range
- $9.99 to $19.50
- Next report
- Nov 12, 2026
About Trevi Therapeutics
Trevi Therapeutics develops pharmaceutical treatments for respiratory and neurological diseases.
Sector: Health Care
More on Trevi Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $11,540 today
No forecast, no recommendation. This page describes Trevi Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.